BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17936175)

  • 41. Osteoarticular manifestations of antiphospholipid syndrome.
    Tektonidou MG; Moutsopoulos HM
    Rheum Dis Clin North Am; 2006 Aug; 32(3):523-35. PubMed ID: 16880082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid antibodies, antiphospholipid syndrome and infections.
    Sène D; Piette JC; Cacoub P
    Autoimmun Rev; 2008 Feb; 7(4):272-7. PubMed ID: 18295729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
    Descloux E; Durieu I; Cochat P; Vital Durand D; Ninet J; Fabien N; Cimaz R
    Rheumatology (Oxford); 2008 Feb; 47(2):183-7. PubMed ID: 18160418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
    Sugiura-Ogasawara M; Ozaki Y; Nakanishi T; Sato T; Suzumori N; Kumagai K
    Am J Reprod Immunol; 2008 Mar; 59(3):235-41. PubMed ID: 18275516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New treatments for antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Rheum Dis Clin North Am; 2006 Feb; 32(1):129-48, x. PubMed ID: 16504826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The hematologic manifestations of the antiphospholipid syndrome.
    Uthman I; Godeau B; Taher A; Khamashta M
    Blood Rev; 2008 Jul; 22(4):187-94. PubMed ID: 18417261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?
    Asherson RA; Cervera R
    Autoimmun Rev; 2008 Jan; 7(3):164-7. PubMed ID: 18190872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lessons from the "Euro-Phospholipid" project.
    Cervera R
    Autoimmun Rev; 2008 Jan; 7(3):174-8. PubMed ID: 18190874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding.
    Belizna CC; Richard V; Primard E; Kerleau JM; Cailleux N; Louvel JP; Marie I; Hamidou M; Thuillez C; Lévesque H
    Semin Arthritis Rheum; 2008 Jun; 37(6):373-80. PubMed ID: 17977581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antiphospholipid syndrome: from diagnosis to treatment].
    Martinović D; Radić M; Fabijanić D; Fabijanić A
    Lijec Vjesn; 2007; 129(8-9):281-5. PubMed ID: 18198628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
    Tektonidou MG; Sotsiou F; Moutsopoulos HM
    J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font.
    Cervera R; Bucciarelli S; Espinosa G; Gómez-Puerta JA; Ramos-Casals M; Shoenfeld Y; Piette JC; Asherson RA
    Ann N Y Acad Sci; 2007 Jun; 1108():448-56. PubMed ID: 17894009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features, diagnosis, and management of the antiphospholipid syndrome.
    Wong RC; Favaloro EJ
    Semin Thromb Hemost; 2008 Apr; 34(3):295-304. PubMed ID: 18720311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychological development of children born to patients with antiphospholipid syndrome.
    Nacinovich R; Galli J; Bomba M; Filippini E; Parrinello G; Nuzzo M; Lojacono A; Motta M; Tincani A
    Arthritis Rheum; 2008 Mar; 59(3):345-51. PubMed ID: 18311760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morbidity and mortality in the antiphospholipid syndrome.
    Espinosa G; Cervera R
    Curr Opin Pulm Med; 2009 Sep; 15(5):413-7. PubMed ID: 19436204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.